Forging founders faster: Introducing the Cancer Research Horizons Therapeutic Accelerator

Turning a promising discovery into a therapeutic takes more than great science — it requires the right expertise, guidance and network. The Cancer Research Horizons Therapeutic Accelerator, a new accelerator dedicated exclusively to oncology therapeutics, is designed to provide exactly that.

Over four months, researchers will gain:

• Access to Cancer Research UK and Cancer Research Horizons’ world-leading network, from biological assets and clinical networks to datasets, patient insights andcommercialisation expertise
• A curriculum, mentors and community focused exclusively on oncology therapeutics
• £40k funding per team, plus the opportunity to pitch for one of two £250k awards

Applications are now open, and the first cohort will begin in early 2027.

Apply here